US equities
|
NVDA
$233.95
▲+1.34%
MU
$1,074.89
▼-2.05%
TSLA
$370.59
▲+4.65%
SPCX
$158.96
▲+7.35%
SNDK
$1,719.99
▼-3.79%
AMD
$633.91
▲+2.95%
STX
$848.99
▼-10.21%
INTC
$119.33
▼-0.56%
NVDA
$233.95
▲+1.34%
MU
$1,074.89
▼-2.05%
TSLA
$370.59
▲+4.65%
SPCX
$158.96
▲+7.35%
SNDK
$1,719.99
▼-3.79%
AMD
$633.91
▲+2.95%
STX
$848.99
▼-10.21%
INTC
$119.33
▼-0.56%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Conformis, Inc. - Common Stock
(NQ:
CFMS
)
N/A
UNCHANGED
Last Price
Updated: 3:57 PM EDT, Sep 1, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Conformis, Inc. - Common Stock
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Conformis, Inc. (Nasdaq – CFMS), Eneti Inc. (NYSE – NETI), Franchise Group, Inc. (Nasdaq – FRG), NexTier Oilfield Solutions Inc. (NYSE – NEX)
June 26, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
CONFORMIS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Conformis, Inc. - CFMS
June 24, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
Conformis (NASDAQ: CFMS) Merges with restor3d, Inc. to Form an Industry-leading 3D-printed Orthopedic Medical Device Company
June 23, 2023
Conformis, Inc. (NASDAQ: CFMS) and restor3d, Inc., both noteworthy players in the orthopedic industry, have announced a definite merger agreement,
Via
Spotlight Growth
Topics
Artificial Intelligence
Intellectual Property
CFMS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Conformis, Inc. Is Fair to Shareholders
June 23, 2023
From
Halper Sadeh LLC
Via
Business Wire